Labcorp demerger of clinical development business: LH spin-off date and details in full
Laboratory Corporation Of America: Reasonably Priced And Positioned For Growth (NYSE:LH) | Seeking Alpha
LabCorp operating income 2013-2022 | Statista
As it prepares for its clinical development spin-off, Labcorp reports drop in Q4 and FY2022 revenues as demand for Covid-19 testing slows - Triad Business Journal
Labcorp NPS & Customer Reviews | Comparably
SEC Filing | Labcorp
Articles about LabCorp | page 11
Quick Value 6.5.23 ($LH) - by Colin King - Value Don't Lie
Laboratory Corporation of America Company Profile: Stock Performance & Earnings | PitchBook
Laboratory Corp. Of America Holdings (LH) | Finance information
Lab Acquisition | LABORATORY ECONOMiCS
LabCorp Should Look Elsewhere Than PPD - Bloomberg
Unveiling the Investment Potential of Laboratory Corp of America
Laboratory Corp. Of America Holdings Shares Close in on 52-Week Low - Market Mover | Nasdaq